Hospital Respiratory Care
HCNOCTN96

Philips V60 Plus ventilator

NIV and HFT: a powerful union

 

The Philips V60 Plus ventilator* integrates non-invasive ventilation (NIV) and high flow therapy (HFT) on one device.

 

It enhances workflow and patient care efficiency by enabling clinicians to easily, readily and rapidly adjust therapies around constantly changing patient conditions.

Dedicated to early intervention in respiratory failure, it supports speed-to-therapy and patient comfort.

 

Available as a stand alone ventilator or an upgrade to your Philips V60 ventilator.

* May not be available in all markets. Not available for sale in the USA.

    *

    Contact information

    * This field is mandatory

    *
    *
    *
    *
    *
    *
    *
    *
    *

    By specifying your reason for contact we will be able to provide you with a better service.

    We work with partners and distributors who may contact you about this Philips product on our behalf.

    *
    *

    Final CEE consent

    a leap in pediatric mri confidence ambition altona childrens hospital masthead

    Save time and limit disruption

     

    Research shows the process of obtaining an HFT device through to completing patient set-up takes 16.3 minutes on average, as compared to an average of only 3.8 minutes with the V60 Plus.1

     

    • Single device for NIV and HFT
    • Improved workflow
    • Reduced patient disruption

    practice management masthead banner

    Facilitate your ventilation strategies

     

    Many situations benefit from the ability to switch quickly between HFT and NIV strategies:

     

    • Weaning from NIV to HFT
    • Escalating deteriorating patients from HFT to NIV
    • Adjusting therapies as patient condition changes

    a leap in pediatric mri confidence ambition altona childrens hospital masthead

    High Flow Nasal Cannula AC611

     

    Eases the transition from NIV to HFT

     

    • Rates as most comfortable in head-to-head testing2
    • Is available in a range of sizes to fit most patients
    • Adds versatility to your inventory

    community logo

    Made for each other.
    And you.

     

    Choose the best option for your patients from among our range of NIV masks and high flow nasal cannulas. Designed to work together, the V60 Plus ventilator, masks and cannulas:

     

    • Enable therapy transitions
    • Support skin-protective strategies
    • Calculate and display patient leak automatically in NIV modes to aid mask adjustment

    HCNOCTN96

    Already own a Philips V60 ventilator?

     

    The simple V60 HFT activation upgrade removes the hassles of retrieving and setting up a second device, shortens the time needed to escalate therapy, and enables efficient utilisation of your equipment fleet and consumables inventory.

    Better together!

     

    Take your solutions to the next level with our services.

    Services

    Comprehensive services at every stage of your ventilator's lifecycle, utilising your people, processes and technology.

     

    Count on us as your patients count on you. 

    Our portfolio includes:

    • RightFit service agreements
    • Clinical services
    • Respi-Link
    • And more!

     

    www.philips.com/rightfit

    Downloads

    Clinical summary:

    Evidence-based practice for NIV and high flow nasal cannula

    clinical

    Philips V60 Plus ventilator brochure:

    NIV and HFT: a powerful union

    hft brochure

    Whitepaper:

    Providing evidence-based care to patients in need of respiratory support

    whitepaper

    High Flow Nasal Cannula AC611 brochure:

    NIV and HFT: a powerful union

    AC 611 brochure

    References

     

    1. Formative testing report. Philips V60 Product Testing, Results and Recommendations. ResearchWorks May 31, 2017.
    2. Philips High Flow Cannula therapy prototype testing. Conducted by ResearchWorks. 2016.

    You are about to visit a Philips global content page

    Continue

    You are about to visit a Philips global content page

    Continue

    Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.